|
1
|
Igene H: Global health inequalities and
breast cancer: An impending public health problem for developing
countries. Breast J. 14:428–434. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Veronesi U, Boyle P, Goldhirsch A,
Orecchia R and Viale G: Breast cancer. Lancet. 365:1727–1741. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ziegler RG, Anderson WF and Gail MH:
Increasing breast cancer incidence in China: The numbers add up. J
Natl Cancer Inst. 100:1339–1341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gradishar WJ, Anderson BO, Balassanian R,
Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A,
Giordano SH, et al: Breast Cancer Version 2. 2015. J Natl Compr
Canc Netw. 13:448–475. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miller AB, Hoogstraten B, Staquet M and
Winkler A: Reporting results of cancer treatment. Cancer.
47:207–214. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toriola AT and Colditz GA: Trends in
breast cancer incidence and mortality in the United States:
Implications of prevention. Breast Cancer Res Treat. 138:665–673.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Winer EP, Mrrow M, Osborne CK and Harris
JR: Malignant tumors of the breastDe Vita T, Hellman JS and
Rosenberg SA: Cancer, Principle and Practice of Oncology. 6th.
Philadelphia: Lippincott Williams & Wilkins; pp. 16972001
|
|
9
|
Kaufmann M, von Minckwitz G, Bear HD,
Buzdar A, McGale P, Bonnefoi H, Colleoni M, Denkert C, Eiermann W,
Jackesz R, et al: Recommendations from an international expert
panel on the use of neoadjuvant (primary) systemic treatment of
operable breast cancer: New perspectives 2006. Ann Oncol.
18:1927–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uzzan B, Nicolas P, Cucherat M and Perret
GY: Microvessel density as a prognostic factor in women with breast
cancer: A systematic review of the literature and meta-analysis.
Cancer Res. 64:2941–2955. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schwartz GF and Hortobagyi GN: Proceedings
of the consensus conference on neoadjuvant chemotherapy in
carcinoma of the breast, April 26–28, 2003, Philadelphia,
Pennsylvania. Cancer. 100:2512–2532. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bevers TB, Anderson BO, Bonaccio E, Buys
S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE,
et al: NCCN clinical practice guidelines in oncology: Breast cancer
screening and diagnosis. J Natl Compr Canc Netw. 7:1060–1096. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alvarez RH, Booser DJ, Cristofanilli M,
Sahin AA, Strom EA, Guerra L, Kau SW, Gonzalez-Angulo AM,
Hortobagyi GN and Valero V: Phase 2 trial of primary systemic
therapy with doxorubicin and docetaxel followed by surgery,
radiotherapy, and adjuvant chemotherapy with cyclophosphamide,
methotrexate, and 5-fluorouracil based on clinical and pathologic
response in patients with stage IIB to III breast cancer: Long-term
results from the University of Texas M. D. Anderson Cancer Center
Study ID97-099. Cancer. 116:1210–1217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nahleh Z, Sivasubramaniam D, Dhaliwal S,
Sundarajan V and Komrokji R: Residual cancer burden in locally
advanced breast cancer: A superior tool. Curr Oncol. 15:271–278.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pacilio C, Morabito A, Nuzzo F, Gravina A,
Labonia V, Landi G, Rossi E, De Maio E, Di Maio M, D'Aiuto G, et
al: Is epirubicin effective in first-line chemotherapy of
metastatic breast cancer (MBC) after an epirubicin-containing
adjuvant treatment? A single center phase III trial. Br J Cancer.
94:1233–1236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bilbao JI, Rebollo J, Longo JM, Mansilla
F, Muñoz-Galindo L and Vieitez JM: Neoadjuvant intra-arterial
chemotherapy in inflammatory carcinoma of the breast. Br J Radiol.
65:248–251. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murakami M, Kuroda Y, Nishimura S, Sano A,
Okamoto Y, Taniguchi T, Nakajima T, Kobashi Y and Matsusue S:
Intraarterial infusion chemotherapy and radiotherapy with or
without surgery for patients with locally advanced or recurrent
breast cancer. Am J Clin Oncol. 24:185–191. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kitagawa K, Yamakado K, Nakatsuka A,
Tanaka N, Matsumura K, Takeda K and Kawarada Y: Preoperative
transcatheter arterial infusion chemotherapy for locally advanced
breast cancer (stage IIIb) for down-staging and increase of
resectability. Eur J Radiol. 43:31–36. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pacetti P, Mambrini A, Paolucci R,
Sanguinetti F, Palmieri B, Della Seta R, Muttini MP, Fiorentini G
and Cantore M: Intra-arterial chemotherapy: A safe treatment for
elderly patients with locally advanced breast cancer. In Vivo.
20:761–764. 2006.PubMed/NCBI
|
|
20
|
Shimamoto H, Takizawa K, Ogawa Y,
Yoshimatsu M, Yagihashi K, Okazaki H, Kanemaki Y, Nakajima Y, Ohta
T, Ogata H and Fukuda M: Clinical efficacy and value of
redistributed subclavian arterial infusion chemotherapy for locally
advanced breast cancer. Jpn J Radiol. 29:236–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fiorentini G, Tsetis D, Bernardeschi P,
Varveris C, Rossi S, Kalogeraki A, Athanasakis E, Dentico P,
Kanellos P, Biancalani M, et al: First-line intraarterial
chemotherapy (IAC) with epirubicin and mitoxantrone in locally
advanced breast cancer. Anticancer Res. 23:4339–4345.
2003.PubMed/NCBI
|
|
22
|
Takatsuka Y, Yayoi E, Kobayashi T, Aikawa
T and Kotsuma Y: Neoadjuvantintraarterial chemotherapy in locally
advanced breast cancer: A prospective randomized study. Osaka
Breast Cancer Study Group. Jpn J Clin Oncol. 24:20–25.
1994.PubMed/NCBI
|
|
23
|
Mathew J, Asgeirsson KS, Cheung KL, Chan
S, Dahda A and Robertson JF: Neoadjuvant chemotherapy for locally
advanced breast cancer: A review of the literature and future
directions. Eur J Surg Oncol. 35:113–122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoehne F, Chen S, Mabry H and Giuliano AE:
An update on prognosis in breast cancer patients with extensive
axillary disease. Breast J. 14:76–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang O, Chen C, Wu J, Chen S, Chen X, Liu
G, Hu Z, Lu J, Wu J, Shao Z, et al: Retrospective analysis of 119
Chinese noninflammatory locally advanced breast cancer cases
treated with intravenous combination of vinorelbine and epirubicin
as a neoadjuvant chemotherapy: A median follow-up of 63.4 months.
BMC Cancer. 9:3752009. View Article : Google Scholar : PubMed/NCBI
|
